SEC Form 4 · accession 0000049071-17-000117
HUMANA INC · HUM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roy A Beveridge
Officer — Sr. VP & Chief Medical Officer
Period of report
May 12, 2017
Accepted (ET)
May 15, 2017 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000049071
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Humana Common | May 12, 2017 | M | 14,290 | $81.795 | A | 23,221 | D | |
| Humana Common | May 12, 2017 | M | 15,086 | $102.155 | A | 38,037 | D | |
| Humana CommonF9 | May 12, 2017 | M | 26,023 | $231.9937 | D | 12,284 | D | |
| Humana CommonF10 | May 12, 2017 | F | 1,281 | $229.765 | D | 11,003 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionsF1 | $81.795 | May 12, 2017 | M | 14,290 | D | — | Jun 17, 2020 | Humana Common | 14,290 | 1,291 | D |
| OptionsF2 | $102.155 | May 12, 2017 | M | 15,086 | D | — | Feb 18, 2021 | Humana Common | 15,086 | 0 | D |
| OptionsF3 | $164.645 | holding | — | — | — | — | Feb 24, 2022 | Humana Common | 14,913 | 14,913 | D |
| OptionsF5 | $167.805 | holding | — | — | — | — | Feb 18, 2023 | Humana Common | 14,764 | 14,764 | D |
| OptionsF4 | $217.415 | holding | — | — | — | — | Mar 8, 2024 | Humana Common | 15,997 | 15,997 | D |
| Restricted Stock UnitsF6,F7 | — | holding | — | — | — | — | — | Humana Common | 2,186 | 2,186 | D |
| Restricted Stock UnitsF6,F8 | — | holding | — | — | — | — | — | Humana Common | 3,678 | 3,678 | D |
Explanation of responses
- F1Right to buy pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 06/17/13, vesting in three increments from 06/17/14 to 06/17/16.
- F10Shares swapped for payment of purchase price on incentive stock option exercises using fair market value on May 11, 2017, pursuant to Humana Inc.'s 2011 Stock Incentive Plan.
- F2Right to buy pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/14, vesting in three increments from 02/18/15 to 02/18/17.
- F3Right to buy pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18.
- F4Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 10,998 options vesting in three annual increments, and 4,999 options fully vest three years from the date of grant.
- F5Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19.
- F6Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
- F7Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18.
- F8Restricted stock units granted to reporting person on 03/08/2017, 2,529 shares vesting in three annual increments, and 1,149 shares fully vest three years from the date of grant.
- F9Shares sold at prices ranging from $231.88 to $232.10.